SQZ Biotech raises $16 mln Series B from NanoDimension, Polaris, others
SQZ Biotech has closed a $16 million Series B round led by NanoDimension and Polaris Partners and joined by other existing and new investors, according to a press release. The company also recently named Kris Elverum as chief business officer to lead business development and strategic partnerships. Elverum joins from Novartis.
30 September 2016•1 min read
